Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

USTEKINUMAB vs VALBENAZINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

USTEKINUMAB vs VALBENAZINE: Safety Overview

Metric USTEKINUMAB VALBENAZINE
Total FAERS Reports 85,332 23,191
Deaths Reported 4,519 1,221
Death Rate 5.3% 5.3%
Hospitalizations 17,127 3,225
Average Patient Age 48.1 yrs 60.0 yrs
% Female Patients 60.3% 67.3%
FDA Approval Date N/A Apr 11, 2017
Manufacturer SANDOZ INC Neurocrine Biosciences, Inc.
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription